DIA Global SmartBriefDesigned specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart.&nbsp;Click&nbsp; <a href='http://www.smartbrief.com/dia/index.jsp?sb_code=rss'>here</a> to subscribe.http://www.smartbrief.com/news/dia?sb_code=rsshttp://www.smartbrief.com/images/homepage/hed-smartbrief.gifDIA Global SmartBriefhttp://www.smartbrief.com/news/dia?sb_code=rssen-us16 May 2013 01:55:40 CDTGeneric drug manufacturer pays record finehttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D44A081F9-F8BF-4F45-B9AD-05CCA00044F8%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D44A081F9-F8BF-4F45-B9AD-05CCA00044F8%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssThe generic drug company Ranbaxy USA, a unit of India's largest pharmaceutical company, is paying a fine of $500 million for  -More- 

Early Phase Oncology Trial Management Strategies
This complimentary white paper from Novella Clinical will help small- to mid-size pharma and biotech companies identify key infrastructure elements, foresee patient enrollment issues, and examine trends in trial design and cohort management. Download: Optimizing Early Phase Oncology Clinical Trials.

]]>16 May 2013 01:55:40 CDTTop StoryFrance fines Sanofi for bad-mouthing genericshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D1BC8604C-C1FB-40FF-8F65-140E5C3C4757%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D1BC8604C-C1FB-40FF-8F65-140E5C3C4757%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssFrance's antitrust regulator fined drugmaker Sanofi $52.8 million for casting doubt with doctors and pharmacists about the sa -More- ]]>16 May 2013 01:55:40 CDTEuropeEU calls for pharma, IVD databases to be linkedhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D0EB3E634-46FA-49F5-B1F0-513D03F4F8A2%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D0EB3E634-46FA-49F5-B1F0-513D03F4F8A2%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssThe databases for drugs and IVD clinical-trial registration should be interoperable to streamline the process for companion d -More- ]]>16 May 2013 01:55:40 CDTEuropeSuspension of Italian medtech price cuts upheldhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D323958FD-989E-46C5-8809-CE1DAF863833%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D323958FD-989E-46C5-8809-CE1DAF863833%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssAn Italian court ruling has upheld the suspension of a government mandate to cut prices for medical devices, invalidating the -More- ]]>16 May 2013 01:55:40 CDTEuropeSurvey: China, Malaysia demonstrate strong pharma growthhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DFBEEE7C6-BB4B-48E8-9955-D77E47D62D96%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DFBEEE7C6-BB4B-48E8-9955-D77E47D62D96%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssDespite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will c -More- ]]>16 May 2013 01:55:40 CDTAsia PacificReport names 100 best-selling pharmaceuticalshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DF3FA7AD8-D6A8-49B3-A4C7-0CF6CDAF2663%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DF3FA7AD8-D6A8-49B3-A4C7-0CF6CDAF2663%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssA report by Drugs.com found that the gastrointestinal drug esomeprazole and the antipsychotic aripiprazole were the top-selli -More- ]]>16 May 2013 01:55:40 CDTNorth AmericaCanada extends GMP to cover active pharmaceutical ingredientshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D654B3CAE-CF8E-4C72-BD98-17386457FF99%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D654B3CAE-CF8E-4C72-BD98-17386457FF99%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssCanada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for al -More- ]]>16 May 2013 01:55:40 CDTNorth AmericaPharma success increasingly depends on proving valuehttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D68E5BE71-98AD-41DE-A9DB-5663554CB127%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D68E5BE71-98AD-41DE-A9DB-5663554CB127%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssA drug's success in the marketplace increasingly depends on the drugmaker's ability to prove value and additional benefit ove -More- ]]>16 May 2013 01:55:40 CDTGlobalUSP pharmaceutical training center opens in Ghanahttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DAE98351A-F06C-4E2A-81D5-0D50AC63EC0A%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DAE98351A-F06C-4E2A-81D5-0D50AC63EC0A%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssThe U.S Pharmacopeial Convention has opened the Centre for Pharmaceutical Advancement and Training in Accra, Ghana, to provid -More- ]]>16 May 2013 01:55:40 CDTGlobalEastern African Community seeks to strengthen local pharmahttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D080B1E16-C479-4DAF-8D03-7B5A390D7D3C%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D080B1E16-C479-4DAF-8D03-7B5A390D7D3C%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssThe newly announced Pharmaceutical Manufacturing Plan of Action of the East African Community will focus on challenges caused -More- ]]>16 May 2013 01:55:40 CDTGlobalPlan your attendance at the 10th anniversary of LACCRhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DD1D599EB-B61F-417A-962D-45C07C1F638B%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DD1D599EB-B61F-417A-962D-45C07C1F638B%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssThe program is now available for the premier educational event in clinical research across Latin America – the 10th Lat -More- ]]>16 May 2013 01:55:40 CDTDIA NewsReceive discounts on event registration and more with DIA membershiphttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DA590C56A-F918-4DBD-A35E-2DFEDE83EB50%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3DA590C56A-F918-4DBD-A35E-2DFEDE83EB50%26brief%3Ddia%26sb_code%3Drss%26%26campaign%3DrssAs a DIA member, you receive discount pricing on more than 200 events and training courses each year, including more than 100 -More- 

]]>16 May 2013 01:55:40 CDTDIA NewsThat which is always within our reach is always the last thing we take; and the chances are, that what we can do every day, we never do at all.http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D119E3201-E6F6-4306-B381-CE4ECF4F39B2%26brief%3Ddia%26sb_code%3Drss%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DA8E640EC-C872-48E1-A91D-17770616E81A%26copyid%3D119E3201-E6F6-4306-B381-CE4ECF4F39B2%26brief%3Ddia%26sb_code%3Drss%26campaign%3DrssL.E. Landon,British writer and poet -More- ]]>16 May 2013 01:55:40 CDTSmartQuote